Sign In to Follow Application
View All Documents & Correspondence

N 4 (1 H Pyrazolo [3,4 B] Pyrazin 6 Yl) Phenyl] Sulfonamides And Their Use As Pharmaceuticals

Abstract: N-[4-(1 H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula I, wherein Ar, R1, R2 and n have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds which modulate protein kinase activity, specifically the activity of serum and glucocorticoid regulated kinase (SGK), in particular of serum and glucocorticoid regulated kinase isoform 1 (SGK-1, SGK1), and are suitable for the treatment of diseases in which SGK activity is inappropriate, for example degenerative joint disorders or inflammatory processes such as osteoarthritis or rheumatism. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use as pharmaceuticals, and pharmaceutical compositions comprising them.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
19 September 2011
Publication Number
25/2013
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

SANOFI
174, AVENUE DE FRANCE, 75013 PARIS

Inventors

1. MARC NAZARE
C/O SANOFI-AENTIS DEUTSCHLAND GMBH, 65926 FRANKFURT AM MAIN
2. NIS HALLAND
C/O SANOFI-AENTIS DEUTSCHLAND GMBH, 65926 FRANKFURT AM MAIN
3. FRIEDEMANN SCHMIDT
C/O SANOFI-AENTIS DEUTSCHLAND GMBH, 65926 FRANKFURT AM MAIN
4. TILO WEISS
C/O SANOFI-AENTIS DEUTSCHLAND GMBH, 65926 FRANKFURT AM MAIN
5. UWE DIETZ
C/O SANOFI-AENTIS DEUTSCHLAND GMBH, 65926 FRANKFURT AM MAIN
6. ARMIN HOFMEISTER
C/O SANOFI-AENTIS DEUTSCHLAND GMBH, 65926 FRANKFURT AM MAIN

Specification

ATTACHED

Documents